<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26887" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Paraneoplastic Pemphigus</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kappius</surname>
            <given-names>Rachael H.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ufkes</surname>
            <given-names>Nicole A.</given-names>
          </name>
          <aff>Medical University of South Carolina</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thiers</surname>
            <given-names>Bruce H.</given-names>
          </name>
          <aff>Medical University of South Carolina</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Rachael Kappius declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nicole Ufkes declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bruce Thiers declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26887.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Paraneoplastic pemphigus (PNP) is a rare autoimmune disease that is almost always associated with confirmed or occult malignancy. Patients typically present with painful and extensive mucosal and cutaneous involvement, with an overall poor prognosis. No formal diagnostic or treatment protocols currently exist for PNP. This activity reviews the epidemiology, pathophysiology, clinical presentation, differential diagnosis, and management of patients with PNP while emphasizing the role of an interprofessional team in improving care for these patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the clinical presentation of a patient with paraneoplastic pemphigus, reviewing the five major clinical subtypes that can present and the most common early presenting symptom.</p></list-item><list-item><p>Identify the potential complications of paraneoplastic pemphigus.</p></list-item><list-item><p>Summarize histopathological, clinical, and immunological criteria used to diagnose paraneoplastic pemphigus.</p></list-item><list-item><p>Review the importance of coordination of care among interprofessional team members to improve outcomes for patients affected by paraneoplastic pemphigus.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26887&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26887">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26887.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Paraneoplastic pemphigus (PNP) is a rare, autoimmune-mediated mucocutaneous disease that is almost always associated with an underlying neoplasm. Pemphigus comprises a group of IgG-mediated autoimmune bullous diseases in which autoantibodies react with desmosomes, the cell-to-cell adhesion structures between keratinocytes, resulting in painful skin erosions and blisters. Researchers have identified three significant forms of pemphigus: pemphigus foliaceus, pemphigus vulgaris (most common type), and paraneoplastic pemphigus.<xref ref-type="bibr" rid="article-26887.r1">[1]</xref><xref ref-type="bibr" rid="article-26887.r2">[2]</xref></p>
        <p>Paraneoplastic pemphigus typically presents with painful mucosal erosions and dusky patches on the skin that later desquamate. A variety of lesions with differing morphologies, ranging from flaccid blisters to widespread lichenoid eruptions, have been seen in paraneoplastic pemphigus patients. However, shared by all patients is the presence of widespread, and often severe, mucosal lesions that can be the earliest presenting symptom of the disease.<xref ref-type="bibr" rid="article-26887.r3">[3]</xref><xref ref-type="bibr" rid="article-26887.r4">[4]</xref>&#x000a0;Extensive epidermal loss can result in extreme dehydration, protein depletion, and an increased risk of infection. Patients often require intensive care and should be managed, similar to burn patients. Adults ages 45 to 70 years are most commonly affected, though children can develop PNP.<xref ref-type="bibr" rid="article-26887.r5">[5]</xref>&#x000a0;It was first identified in 1990 by Anhalt, who proposed the initial set of diagnostic criteria.<xref ref-type="bibr" rid="article-26887.r6">[6]</xref>&#x000a0;The term &#x0201c;paraneoplastic autoimmune multiorgan syndrome&#x0201d; (PAMS) has since been coined to account for the variable non-bullous cutaneous manifestation and additional systemic findings, such as bronchiolitis obliterans.<xref ref-type="bibr" rid="article-26887.r5">[5]</xref><xref ref-type="bibr" rid="article-26887.r7">[7]</xref>&#x000a0;Mortality rates approach 90% in PNP.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref></p>
      </sec>
      <sec id="article-26887.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Lymphoproliferative neoplasms are the most commonly identified underlying diseases in paraneoplastic pemphigus development, accounting for up to 84% of cases.<xref ref-type="bibr" rid="article-26887.r5">[5]</xref><xref ref-type="bibr" rid="article-26887.r9">[9]</xref>&#x000a0;Approximately two-thirds of PNP cases are due to non-Hodgkin lymphoma and chronic lymphocytic lymphoma.<xref ref-type="bibr" rid="article-26887.r10">[10]</xref><xref ref-type="bibr" rid="article-26887.r11">[11]</xref> However, other neoplasms are associated with PNP development, such as sarcomas, particularly follicular dendritic cell sarcomas,<xref ref-type="bibr" rid="article-26887.r12">[12]</xref><xref ref-type="bibr" rid="article-26887.r13">[13]</xref>&#x000a0;thymomas,<xref ref-type="bibr" rid="article-26887.r14">[14]</xref>&#x000a0;squamous cell carcinomas of the skin, tongue, vagina, and carcinomas of the lung, stomach, and colon.<xref ref-type="bibr" rid="article-26887.r4">[4]</xref><xref ref-type="bibr" rid="article-26887.r15">[15]</xref><xref ref-type="bibr" rid="article-26887.r16">[16]</xref></p>
        <p>In adults, non-Hodgkin lymphoma is the most frequent underlying neoplasm (38.6%), followed by chronic lymphocytic leukemia (18.4%), and Castleman disease (18.4%).<xref ref-type="bibr" rid="article-26887.r3">[3]</xref>&#x000a0;Non-hematological neoplasms account for 16% of cases. Paraneoplastic pemphigus in children and adolescents is often the presenting sign of Castleman disease.<xref ref-type="bibr" rid="article-26887.r17">[17]</xref></p>
        <p>Recently, researchers have identified increased susceptibility to paraneoplastic pemphigus development in patients with HLA Class II Drb1*03 allele<xref ref-type="bibr" rid="article-26887.r18">[18]</xref>&#x000a0;and HLA-Cw*14.<xref ref-type="bibr" rid="article-26887.r19">[19]</xref>&#x000a0;These alleles are more common in Caucasian and Chinese populations, respectively. In contrast, HLA-DR4 and HLA-DR1-14 increase susceptibility to pemphigus vulgaris and pemphigus foliaceus, but have not shown an association with the development of PNP.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref></p>
      </sec>
      <sec id="article-26887.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The exact incidence of paraneoplastic pemphigus (PNP) is unknown. It is much less common than pemphigus vulgaris or pemphigus foliaceus, comprising only 3 to 5% of all pemphigus cases.<xref ref-type="bibr" rid="article-26887.r5">[5]</xref><xref ref-type="bibr" rid="article-26887.r2">[2]</xref></p>
        <p>Paraneoplastic pemphigus typically develops in adults 45 to 70 years old.<xref ref-type="bibr" rid="article-26887.r5">[5]</xref>&#x000a0;The&#x000a0;disease can occur in children and is usually associated with Castleman disease.<xref ref-type="bibr" rid="article-26887.r20">[20]</xref><xref ref-type="bibr" rid="article-26887.r17">[17]</xref>&#x000a0;Men and women seem to share equal predilection.<xref ref-type="bibr" rid="article-26887.r3">[3]</xref></p>
        <p>In a study of 496 patients with internal malignancy, 25 of these patients developed pemphigus (5%). The mean age of PNP patients was 64.7 years and PNP development correlated with increasing age.<xref ref-type="bibr" rid="article-26887.r21">[21]</xref>&#x000a0;Most cases of paraneoplastic pemphigus arise in patients with a known underlying neoplasm that may or may not have received previous treatment.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref> However, if no known neoplasm exists in a patient presenting with PNP signs and symptoms, an exhaustive workup for occult neoplasm is urgently indicated.<xref ref-type="bibr" rid="article-26887.r4">[4]</xref></p>
      </sec>
      <sec id="article-26887.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The following proteins, among others, are targeted by autoantibodies in paraneoplastic pemphigus:<xref ref-type="bibr" rid="article-26887.r3">[3]</xref><xref ref-type="bibr" rid="article-26887.r11">[11]</xref><xref ref-type="bibr" rid="article-26887.r22">[22]</xref><xref ref-type="bibr" rid="article-26887.r23">[23]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Desmoglein types 1 (160 kD) and 3 (130 kD) &#x02013; Desmosome, extracellular (Dsg1, Dsg3)</p>
          </list-item>
          <list-item>
            <p>Desmoplakin 1 (250 kD) and 2 (210 kD) &#x02013; Desmosome, intracellular</p>
          </list-item>
          <list-item>
            <p>Bullous pemphigoid antigen 1 (230 kD)&#x02013; Hemidesmosome/lamina lucida (BP230)</p>
          </list-item>
          <list-item>
            <p>Envoplakin (210 kD) &#x02013; Desmosome, intracellular</p>
          </list-item>
          <list-item>
            <p>Epiplakin (more than 700 kD) - Desmosome, intracellular</p>
          </list-item>
          <list-item>
            <p>Periplakin (190 kD) &#x02013; Desmosome, intracellular</p>
          </list-item>
          <list-item>
            <p>Alpha-2-macroglobulin-like-1 antigen (170 kD) (A2ML1) - protease inhibitor<xref ref-type="bibr" rid="article-26887.r24">[24]</xref><xref ref-type="bibr" rid="article-26887.r25">[25]</xref><xref ref-type="bibr" rid="article-26887.r26">[26]</xref></p>
          </list-item>
        </list>
        <p>Autoantibodies against plakin proteins are characteristic of PNP and not typically found in other forms of pemphigus.<xref ref-type="bibr" rid="article-26887.r23">[23]</xref><xref ref-type="bibr" rid="article-26887.r27">[27]</xref><xref ref-type="bibr" rid="article-26887.r28">[28]</xref></p>
      </sec>
      <sec id="article-26887.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histologic features of paraneoplastic pemphigus (PNP) include epidermal acantholysis and clefting, necrotic keratinocytes, vacuolization of the basal layer, and lymphocyte exocytosis.<xref ref-type="bibr" rid="article-26887.r29">[29]</xref><xref ref-type="bibr" rid="article-26887.r3">[3]</xref><xref ref-type="bibr" rid="article-26887.r30">[30]</xref> Dyskeratosis with suprabasal acantholysis is a distinctive feature of PNP.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref>&#x000a0;However, histopathologic characteristics will vary with the particular patient&#x02019;s clinical lesion morphology, ranging from non-inflammatory bullous lesions to dense lichenoid inflammatory infiltrates.<xref ref-type="bibr" rid="article-26887.r30">[30]</xref><xref ref-type="bibr" rid="article-26887.r29">[29]</xref><xref ref-type="bibr" rid="article-26887.r31">[31]</xref> Interface dermatitis secondary to a T-cell mediated autoimmune reaction and subsequent infiltration into the epidermis suggests a cell-mediated cytotoxicity component to PNP.<xref ref-type="bibr" rid="article-26887.r32">[32]</xref></p>
        <p>Paraneoplastic pemphigus may mimic erythema multiforme both clinically and histologically, particularly if lesions are characterized by predominant interface dermatitis with necrotic keratinocytes. Therefore direct immunofluorescence and indirect immunofluorescence are imperative for correct diagnosis. Similarly, the characteristic suprabasal acantholysis and blister formation seen in paraneoplastic pemphigus are essentially identical to that observed in pemphigus vulgaris, although other vulgaris features are typically absent.<xref ref-type="bibr" rid="article-26887.r29">[29]</xref>&#x000a0;Lichen planus-like lesions in PNP may exhibit bands of lymphohistiocytic infiltrates in the papillary dermis accompanied by vacuolar interface change.<xref ref-type="bibr" rid="article-26887.r30">[30]</xref><xref ref-type="bibr" rid="article-26887.r11">[11]</xref></p>
        <p>Histological findings of interface dermatitis, vacuolar changes, and dyskeratotic keratinocytes should raise suspicion for PNP, as these features are not present in classic pemphigus.<xref ref-type="bibr" rid="article-26887.r27">[27]</xref></p>
      </sec>
      <sec id="article-26887.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Paraneoplastic pemphigus (PNP) almost always presents with early mucosal involvement, typically with vesicles or bullae that result in painful mucocutaneous erosions and severe stomatitis, similar in morphology to pemphigus vulgaris.<xref ref-type="bibr" rid="article-26887.r10">[10]</xref><xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r33">[33]</xref><xref ref-type="bibr" rid="article-26887.r9">[9]</xref>&#x000a0;In fact, oral mucositis refractory to treatment may be the only presenting symptom of PNP.<xref ref-type="bibr" rid="article-26887.r4">[4]</xref>&#x000a0;Mucous membrane lesions of the oral cavity may progress to involve the vermilion borders, tongue, oropharynx, nasopharynx, and esophagus. The conjunctiva and anogenital region can also be affected.<xref ref-type="bibr" rid="article-26887.r34">[34]</xref><xref ref-type="bibr" rid="article-26887.r3">[3]</xref><xref ref-type="bibr" rid="article-26887.r35">[35]</xref>&#x000a0;Severe erosions, crusting, and ulceration on the tongue, lips, and palate may resemble Stevens-Johnson syndrome or erythema multiforme.<xref ref-type="bibr" rid="article-26887.r22">[22]</xref></p>
        <p>Cutaneous involvement in paraneoplastic pemphigus is typically diffuse and can exhibit considerable variation in appearance and morphology.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r7">[7]</xref> Cutaneous manifestations often present after mucosal symptoms, ranging from pruritic red-purple papules, targetoid erythematous plaques, diffuse erythema, flaccid erosive blisters, and widespread exfoliative erythroderma.<xref ref-type="bibr" rid="article-26887.r10">[10]</xref>&#x000a0;For this reason, PNP can mimic other skin diseases such as lichen planus, erythema multiforme, bullous pemphigoid, pemphigus vulgaris, and graft-versus-host disease. The variety of clinical manifestations is likely secondary to the range of autoantibodies with which patients can potentially present.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref>&#x000a0;Five major clinical subtypes of paraneoplastic pemphigus have been identified: pemphigus-like, bullous pemphigoid-like, erythema multiforme-like, graft-versus-host disease-like, and lichen planus-like.</p>
        <p>
<bold>Clinical Presentations of Paraneoplastic Pemphigus</bold>
<xref ref-type="bibr" rid="article-26887.r3">[3]</xref>
<xref ref-type="bibr" rid="article-26887.r5">[5]</xref>
<xref ref-type="bibr" rid="article-26887.r7">[7]</xref>
<xref ref-type="bibr" rid="article-26887.r8">[8]</xref>
</p>
        <list list-type="order">
          <list-item>
            <p><bold>Pemphigus-like</bold>
<list list-type="bullet"><list-item><p>Clinical: superficial vesicles, flaccid blisters, crusted erosions</p></list-item><list-item><p>Histopathology: intraepidermal and or suprabasal acantholysis with surrounding mononuclear cells</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Pemphigoid-like</bold>
<list list-type="bullet"><list-item><p>Clinical: scaling erythematous papules and tense blisters</p></list-item><list-item><p>Histopathology: dyskeratosis with subepidermal splitting, with or without basal cell vacuolization; sparse mononuclear infiltrate at the dermal-epidermal junction</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Erythema Multiforme-like</bold>
<list list-type="bullet"><list-item><p>Clinical: Scaling erythematous papules; severe, polymorphic cutaneous or mucosal lesions</p></list-item><list-item><p>Histopathology: Dyskeratosis with or without accompanying epidermal acantholysis; perivascular infiltrates</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Graft-versus-Host Disease-like</bold>
<list list-type="bullet"><list-item><p>Clinical: Diffuse red, scaly, sometimes dusky, papules</p></list-item><list-item><p>Histopathology: hyper-ortho/parakeratosis and variable dyskeratosis with or without vacuolar interface change</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p><bold>Lichen Planus- like</bold>
<list list-type="bullet"><list-item><p>Clinical: small red to violaceous flat-topped scaly papules</p></list-item><list-item><p>Histopathology: hyperkeratosis with a lichenoid infiltrate at the dermal-epidermal junction</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>In a study of 104 patients, an erythema multiforme-like presentation was most common (56%), followed by PV-like (41%), lichen planus-like (13%), and bullous pemphigoid-like (3%).<xref ref-type="bibr" rid="article-26887.r24">[24]</xref>&#x000a0;However, others report an equal incidence of clinical subtypes amongst PNP patients.<xref ref-type="bibr" rid="article-26887.r7">[7]</xref> Also, patients have presented with psoriasiform and pustular lesions.</p>
        <p>An individual patient may have various forms of coexisting cutaneous lesions and have lesions that transform to a different morphology. Blisters and erythema multiforme-like lesions affecting the palms and soles can help differentiate PNP from pemphigus vulgaris, which typically does not involve these surfaces.</p>
        <p>
<bold>Extracutaneous Involvement</bold>
</p>
        <p>Paraneoplastic pemphigus can affect other types of epithelia. Thus internal organ involvement is common, particularly in the eyes, lungs, gastrointestinal tract, thyroid, kidney.<xref ref-type="bibr" rid="article-26887.r27">[27]</xref>&#x000a0;Incidence of pulmonary involvement ranges from 59.1% to 92.8% of PNP cases.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r7">[7]</xref> Eye involvement occurs in up to 70% of patients and may lead to irreversible blindness.<xref ref-type="bibr" rid="article-26887.r36">[36]</xref><xref ref-type="bibr" rid="article-26887.r34">[34]</xref> Ocular presentations of PNP include pseudomembranous conjunctivitis with progressive scarring, conjunctival or corneal erosions and ulcerations, eyelid thickening, and pterygium.<xref ref-type="bibr" rid="article-26887.r22">[22]</xref><xref ref-type="bibr" rid="article-26887.r27">[27]</xref> Cases reports exist of corneal melting.<xref ref-type="bibr" rid="article-26887.r36">[36]</xref></p>
        <p>Respiratory involvement can present as dyspnea, dry cough, obstructive lung disease, or secondary pneumonia, with potential for rapid progression to bronchiolitis obliterans.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r37">[37]</xref>&#x000a0;Paraneoplastic pemphigus with bronchiolitis obliterans is associated with high mortality rates.<xref ref-type="bibr" rid="article-26887.r38">[38]</xref> The pathologic mechanism resulting in bronchiolitis obliterans development is not completely understood. The presumption is that autoantibodies play a role, causing loss of adhesion between respiratory epithelial cells and subsequent bronchiole obstruction.<xref ref-type="bibr" rid="article-26887.r27">[27]</xref>&#x000a0;Specifically, antibodies targeting epiplakin have been implicated.<xref ref-type="bibr" rid="article-26887.r23">[23]</xref></p>
        <p>In a study of 58 PNP patients, 39% experienced significant muscle weakness. Myasthenia gravis was ultimately diagnosed in 35% of these patients as they exhibited high titers of anti-acetylcholine receptor or anti-acetylcholinesterase antibodies.<xref ref-type="bibr" rid="article-26887.r39">[39]</xref> Interestingly, the levels of these antibodies significantly increased in patients with PNP with dyspnea. Patients with underlying thymomas showed an expected higher frequency of myasthenic symptoms than those with other underlying neoplasms.</p>
      </sec>
      <sec id="article-26887.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>No formally accepted diagnostic criteria exist for paraneoplastic pemphigus.<xref ref-type="bibr" rid="article-26887.r40">[40]</xref>&#x000a0;Diagnostic confirmation is typically by a combination of clinical presentation, histology, direct and indirect immunofluorescence microscopy, and immune serology. Immunoprecipitation and immunoblotting are both specific and sensitive for the detection of circulating autoantibodies.<xref ref-type="bibr" rid="article-26887.r31">[31]</xref><xref ref-type="bibr" rid="article-26887.r41">[41]</xref>&#x000a0;Biopsy should ideally be taken from an early lesion so that an intact specimen can be examined (mature bullae typically rupture easily). Providers should avoid punch biopsy due to possible epidermal detachment from the dermis.</p>
        <p>Anhalt&#x02019;s et al. original PNP diagnostic criteria have as their basis on five immunological, histological, and clinical features:<xref ref-type="bibr" rid="article-26887.r6">[6]</xref></p>
        <p>
<bold>Clinical</bold>
</p>
        <p>Painful mucosal erosions with or without accompanying polymorphous cutaneous lesions in the setting of an underlying malignancy</p>
        <p>
<bold>Histopathology</bold>
</p>
        <p>Suprabasal (intraepidermal) acantholysis, interface dermatitis, and keratinocyte necrosis</p>
        <p>
<bold>DIF (Direct Immunofluorescence)</bold>
</p>
        <p>IgG and complement (C3) deposition within the intercellular spaces of the epidermis, often with linear, granular basement membrane zone deposition</p>
        <p>
<bold>IIF (Indirect Immunofluorescence)</bold>
</p>
        <p>Detection of autoantibodies targeting intercellular proteins found in transitional or stratified squamous epithelia</p>
        <p>
<bold>Immunoprecipitation</bold>
</p>
        <p>Precipitation of a characteristic proteins desmoplakin 1 (250 kD), bullous pemphigoid antigen (230 kD), desmoplakin 2 (210 kD), periplakin (190kD), alpha-2-macroglobulin-like-1 antigen (170 kD)</p>
        <p>Joly et al. evaluated these diagnostic criteria and identified three features with both high specificity (84%-100%) and sensitivity (82-86%).<xref ref-type="bibr" rid="article-26887.r31">[31]</xref>&#x000a0;These were:</p>
        <list list-type="order">
          <list-item>
            <p>Presence of an underlying lymphoproliferative disorder</p>
          </list-item>
          <list-item>
            <p>An IIF positive for autoantibodies on rat bladder</p>
          </list-item>
          <list-item>
            <p>Detection of autoantibodies against periplakin and envoplakin on immunoblot</p>
          </list-item>
        </list>
        <p>As more atypical presentations and disease manifestations of PNP get reported, researchers continue to propose variants to the classic diagnostic criteria. For instance, Camisa and Helm created diagnostic guidelines that classify criteria as either major or minor. PNP diagnosis requires three major criteria, or two major and two minor criteria.<xref ref-type="bibr" rid="article-26887.r42">[42]</xref><xref ref-type="bibr" rid="article-26887.r8">[8]</xref></p>
        <p>
<bold>Major Criteria</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Polymorphic mucocutaneous eruptions</p>
          </list-item>
          <list-item>
            <p>Concomitant internal neoplasm</p>
          </list-item>
          <list-item>
            <p>Serum antibodies with a specific immunoprecipitation pattern</p>
          </list-item>
        </list>
        <p>
<bold>Minor Criteria</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Acantholysis observed histologically</p>
          </list-item>
          <list-item>
            <p>DIF displaying intercellular and basement membrane staining</p>
          </list-item>
          <list-item>
            <p>&#x000a0;IIF staining positive on rat bladder epithelium</p>
          </list-item>
        </list>
        <p>
<bold>Diagnosis of PNP</bold>
</p>
        <p><bold>Histopathology: </bold>Dyskeratosis with suprabasal acantholysis with possible basilar vacuolization are classic histological features of PNP.<xref ref-type="bibr" rid="article-26887.r11">[11]</xref><xref ref-type="bibr" rid="article-26887.r43">[43]</xref>&#x000a0;However, the histopathologic findings correlate and vary with an individual patient&#x02019;s clinical lesions that may be a result of a primarily humoral or cellular immune response, or a mixture of both. Overlapping patterns between lesions are common. Additionally, acantholysis is not specific for paraneoplastic pemphigus or pemphigus diseases as a whole, as it may present in several other pathologies.<xref ref-type="bibr" rid="article-26887.r43">[43]</xref></p>
        <p><bold>Direct Immunofluorescence (DIF): </bold>Typically reveals intercellular IgG and C3 in the epidermis, often in a net-like pattern between cells. Granular or linear IgG and C3 deposits along the basement membrane zone at the dermal-epidermal junction may also be present - a characteristic unique to PNP compared to other forms of pemphigus.<xref ref-type="bibr" rid="article-26887.r22">[22]</xref><bold>&#x000a0;</bold>However, DIF can be negative in up to 50% of cases.<xref ref-type="bibr" rid="article-26887.r31">[31]</xref>&#x000a0;As such, some researchers have proposed removing DIF as an essential criterion for the diagnosis of PNP.<xref ref-type="bibr" rid="article-26887.r17">[17]</xref></p>
        <p><bold>Indirect Immunofluorescence (IIF): </bold>The presence of circulating antibodies targeting the intercellular proteins of cells within stratified squamous or transitional epithelia are characteristic of PNP.<xref ref-type="bibr" rid="article-26887.r2">[2]</xref><xref ref-type="bibr" rid="article-26887.r22">[22]</xref>&#x000a0;IIF testing of patient serum on plakin-rich rat bladder is especially helpful in discriminating paraneoplastic pemphigus from pemphigus vulgaris or pemphigus foliaceous and may be useful as a specific screening test for diagnosis.<xref ref-type="bibr" rid="article-26887.r31">[31]</xref><xref ref-type="bibr" rid="article-26887.r30">[30]</xref></p>
        <p><bold>Immunoprecipitation and Immunoblot: </bold>Serologic detection of autoantibodies against the 210-kD band of envoplakin and the 190-kD band of periplakin is both sensitive and specific for the diagnosis of PNP.<xref ref-type="bibr" rid="article-26887.r31">[31]</xref> Additionally, PNP serum may react with desmoglein 3, desmoglein 1, desmoplakin I (250 kD), desmoplakin II (210kD), bullous pemphigoid antigen I (230kD), and the recently identified 170-kD antigen, alpha-2-macroglobulin-like-1, among others. One report identified alpha-2-macroglobulin-like-1 autoantibodies present in 50% of PNP patients but found none in patients with other forms of pemphigus.<xref ref-type="bibr" rid="article-26887.r44">[44]</xref>&#x000a0;Immunoblot is considered the gold standard for PNP diagnosis.<xref ref-type="bibr" rid="article-26887.r31">[31]</xref>&#x000a0;Enzyme-linked immunosorbent assays (ELISAs) targeting envoplakin and periplakin have undergone development for paraneoplastic pemphigus diagnosis.<xref ref-type="bibr" rid="article-26887.r41">[41]</xref><xref ref-type="bibr" rid="article-26887.r45">[45]</xref><xref ref-type="bibr" rid="article-26887.r46">[46]</xref></p>
        <p>
<bold>Additional Work-Up</bold>
</p>
        <p>Upon diagnosis of PNP, evaluation for an underlying malignancy is mandatory. Suggested studies and labs include CBC, LDH, flow cytometry, and imaging of the chest, abdomen, and pelvis.</p>
      </sec>
      <sec id="article-26887.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Overall, the treatment of paraneoplastic pemphigus remains controversial and undefined.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r47">[47]</xref>&#x000a0;Early diagnosis and treatment of the underlying malignancy are of utmost importance. Solid tumors should undergo surgical resection with all attempts to block tumor blood supply and minimize manipulation to prevent the hematogenous spread of associated autoantibodies. Infusion of high dose IV-immunoglobulin before and after surgery may reduce the risk of bronchiolitis obliterans, a common complication of PNP, by blocking the action of any released autoantibodies.<xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r30">[30]</xref></p>
        <p>Medical treatment should aim at reducing inflammation, suppressing the immune response, and providing proper wound care. High-dose corticosteroids are considered first-line therapy. Additional systemic immunosuppressants (such as azathioprine or mycophenolate mofetil) may be required if the disease continues to progress or is refractory to treatment with steroids alone.<xref ref-type="bibr" rid="article-26887.r11">[11]</xref><xref ref-type="bibr" rid="article-26887.r27">[27]</xref><xref ref-type="bibr" rid="article-26887.r35">[35]</xref> Therapeutics targeting IgG autoantibodies or B-cells&#x000a0;have also found use in PNP treatment. Rituximab (anti-CD20 B-cell depleting monoclonal antibody) and more recently alemtuzumab (monoclonal antibody targeting CD52 expressed on T and B-cells) have shown some efficacy in PNP with underlying lymphoproliferative malignancies.<xref ref-type="bibr" rid="article-26887.r48">[48]</xref><xref ref-type="bibr" rid="article-26887.r49">[49]</xref><xref ref-type="bibr" rid="article-26887.r50">[50]</xref> Other therapies discussed in the literature include cyclosporine, cyclophosphamide, plasmapheresis, intravenous immunoglobulin, and the use of biosynthetic dressings.<xref ref-type="bibr" rid="article-26887.r3">[3]</xref></p>
        <p>While cutaneous lesions may improve within 12 weeks, mucosal involvement can be poorly responsive to treatment.<xref ref-type="bibr" rid="article-26887.r16">[16]</xref><xref ref-type="bibr" rid="article-26887.r48">[48]</xref>&#x000a0;Though PNP treatment depends on addressing the underlying malignancy, there is not always a parallel evolution between PNP severity and the malignancy&#x02019;s treatment.<xref ref-type="bibr" rid="article-26887.r2">[2]</xref><xref ref-type="bibr" rid="article-26887.r8">[8]</xref> Lesions may continue to progress even if the underlying malignancy is removed or controlled.</p>
        <p>It is essential to recognize and address extracutaneous manifestations and secondary infections promptly. Loss of epidermal integrity places patients at significant risk of infection, dehydration, and electrolyte imbalances. Ideally, PNP patients should receive treatment at a certified burn center for optimal wound care.<xref ref-type="bibr" rid="article-26887.r16">[16]</xref>&#x000a0;Extracutaneous involvement and secondary complications guide specialist consultation. In addition to oncology, therapy for paraneoplastic pemphigus often requires the interprofessional participation of ophthalmology, urology, infectious disease, gastroenterology, and urology/gynecology.</p>
        <p>Occlusive, hydrating dressings should be used to prevent further fluid and electrolyte loss while promoting healing.<xref ref-type="bibr" rid="article-26887.r51">[51]</xref>&#x000a0;Ulcerated skin and mucosal lesions should be cleaned with sterile warm water compresses twice daily, and kept moist with emollients and low adhesive wound dressings, such as petroleum jelly-impregnated gauze. The use of silver dressings is advantageous as they reduce the incidence of infection and also require less frequent dressing changes.<xref ref-type="bibr" rid="article-26887.r52">[52]</xref>&#x000a0;Manage pain with topical analgesics and opioids as needed.<xref ref-type="bibr" rid="article-26887.r53">[53]</xref>&#x000a0;For selected lesions, a potent corticosteroid or calcineurin inhibitor can be topically applied. Orally applied topical corticosteroids (such as triamcinolone acetonide gel) and analgesic mouthwashes can be useful for oral lesions.<xref ref-type="bibr" rid="article-26887.r53">[53]</xref> Bioengineered dressings used for burn patients may be necessary in severe cases. Nasogastric tubes are required if a patient is unable to eat due to painful oropharyngeal lesions. Inadequate protein intake hampers wound healing; thus, nutritional protein supplementation may show benefits.<xref ref-type="bibr" rid="article-26887.r52">[52]</xref>&#x000a0;Bedridden patients should receive frequent position changes to prevent pressure ulcer formation.</p>
        <p>Anti-septic baths and topical antimicrobials are preferable to systemic medications.<xref ref-type="bibr" rid="article-26887.r52">[52]</xref>&#x000a0;However, severe secondary infections must be identified early and treated with appropriate systemic antimicrobials to prevent sepsis. Patients with bronchiolitis obliterans are especially susceptible to secondary pneumonia requiring systemic antibiotics.&#x000a0;Any patient with a new fever, hypotension, tachycardia, or changes in mental status should receive a full infectious workup for suspected sepsis.</p>
        <p>Also, prophylaxis for side effects of prolonged corticosteroid&#x000a0;and other immunosuppressive therapies merits provider focus.</p>
      </sec>
      <sec id="article-26887.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for paraneoplastic pemphigus (PNP) include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Stevens-Johnson syndrome/erythema multiforme</p>
          </list-item>
          <list-item>
            <p>Toxic epidermal necrolysis</p>
          </list-item>
          <list-item>
            <p>Lichen planus</p>
          </list-item>
          <list-item>
            <p>Graft-versus-host disease</p>
          </list-item>
          <list-item>
            <p>Herpes simplex virus</p>
          </list-item>
          <list-item>
            <p>Drug-induced pemphigus</p>
          </list-item>
          <list-item>
            <p>Pemphigus vulgaris</p>
          </list-item>
          <list-item>
            <p>Mucous membrane pemphigoid</p>
          </list-item>
          <list-item>
            <p>Major aphthous or chemotherapy-induced stomatitis</p>
          </list-item>
          <list-item>
            <p>Staphylococcal scalded skin syndrome</p>
          </list-item>
          <list-item>
            <p>Bullous pemphigoid</p>
          </list-item>
        </list>
        <p>Correct diagnosis relies on a combination of clinical presentation, histopathology, DIF/IIF, and immunoblot or immunoprecipitation studies.</p>
      </sec>
      <sec id="article-26887.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Even with treatment, paraneoplastic pemphigus (PNP) outcomes are often poor, with mortality rates up to 90%.<xref ref-type="bibr" rid="article-26887.r2">[2]</xref><xref ref-type="bibr" rid="article-26887.r8">[8]</xref><xref ref-type="bibr" rid="article-26887.r54">[54]</xref><xref ref-type="bibr" rid="article-26887.r10">[10]</xref>&#x000a0;Infection from widespread skin loss and immunosuppressive therapy, the progression of the associated malignancy, and bronchiolitis obliterans development are common causes of death. Less aggressive or resectable neoplasms are typically associated with improved prognoses.<xref ref-type="bibr" rid="article-26887.r3">[3]</xref><xref ref-type="bibr" rid="article-26887.r55">[55]</xref></p>
        <p>The presence of keratinocyte necrosis and cutaneous lesions resembling erythema multiforme, especially when accompanied by extensive mucosal and cutaneous lesions at presentation, are two factors associated with a worse prognosis.<xref ref-type="bibr" rid="article-26887.r47">[47]</xref>&#x000a0;In a study of 144 patients with PNP and underlying hematologic malignancy, the presence of envoplakin autoantibodies and bronchiolitis obliterans development correlated with an increased risk of death. Toxic epidermal necrolysis-like or bullous pemphigoid-like clinical presentations were associated with&#x000a0;decreased survival.<xref ref-type="bibr" rid="article-26887.r38">[38]</xref></p>
        <p>Concentrations of serum IgG autoantibodies against Dsg1 and Dsg3 may parallel the clinical symptoms. Thus Dsg-ELISA can be a serological marker of disease activity in pemphigus.<xref ref-type="bibr" rid="article-26887.r11">[11]</xref></p>
      </sec>
      <sec id="article-26887.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Ocular involvement in paraneoplastic pemphigus is common and thus should be closely monitored. Early ophthalmology referral is key to prevent vision loss and blindness. Ocular therapy may include the use of topical corticosteroid drops, artificial tears, and 10% N-acetylcysteine, and sometimes requires surgical intervention in cases of extensive scarring.<xref ref-type="bibr" rid="article-26887.r36">[36]</xref></p>
        <p>Bronchiolitis obliterans, presenting with a dry cough, dyspnea, and hypoxemia, affects an estimated 30% to 90% of PNP patients.<xref ref-type="bibr" rid="article-26887.r54">[54]</xref><xref ref-type="bibr" rid="article-26887.r56">[56]</xref>&#x000a0;Respiratory failure due to bronchiolitis obliterans development was identified as the most common cause of death in a study of PNP patients with Castleman disease. Biopsy of the lungs may reveal bronchiole fibrosis, dense lymphohistiocytic infiltrate, and autoantibody deposition in bronchial epithelia.<xref ref-type="bibr" rid="article-26887.r54">[54]</xref><xref ref-type="bibr" rid="article-26887.r30">[30]</xref>&#x000a0;Possible causes of bronchiolitis obliterans include autoantibody-mediated injury, infection, or drug toxic side effects.<xref ref-type="bibr" rid="article-26887.r54">[54]</xref>&#x000a0;For resectable tumors, infusion of high dose IV-immunoglobulin before and after surgery may reduce the risk of bronchiolitis obliterans development by blocking circulating autoantibodies released from the tumor. Results from a study of Japanese PNP patients suggests bronchiolitis obliterans development is associated with epiplakin autoantibodies, as epiplakin-negative PNP patients did not develop bronchiolitis obliterans.<xref ref-type="bibr" rid="article-26887.r23">[23]</xref>&#x000a0;Repeated infections can further complicate bronchiolitis obliterans.</p>
        <p>Epidermal erosions and blister rupture may cause significant fluid, protein, and electrolyte losses resulting in dehydration and electrolyte imbalances. Breaching and subsequent loss of the skin barrier also predispose patients to infection and sepsis, compounded by the effect of immunosuppressive therapies used to treat PNP and the underlying malignancy. Mucosal lesions are often resistant and persistent even after intensive treatment.</p>
        <p>Dehydration and malnutrition secondary to painful oropharyngeal erosions may occur. Thus a nasogastric tube may be required in some patients.</p>
      </sec>
      <sec id="article-26887.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Diffuse blistering may lead to the development of contractures. Physical therapy and rehabilitation may be warranted in such patients to regain function and movement.&#x000a0;Ulcerated skin and mucosal lesions should be cleaned with sterile warm water compresses twice daily, and kept moist with emollients and low adhesive wound dressings, such as petroleum jelly-impregnated gauze. The use of silver dressings is advantageous as they reduce the incidence of infection and also require less frequent dressing changes.</p>
      </sec>
      <sec id="article-26887.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>There is not much high-quality evidence for the treatment and diagnosis of paraneoplastic pemphigus (PNP), both due to difficulty in diagnosis with various clinical presentations and low disease incidence.<xref ref-type="bibr" rid="article-26887.r57">[57]</xref> Further investigation is required to create evidence-based diagnostic criteria, treatment protocols, and standard of care recommendations. Providers, particularly dermatologists, hematologist-oncologists, internists, and ophthalmologists, should be educated regarding the numerous presentations of PNP to encourage early diagnosis and treatment.</p>
        <p>Healthcare staff with adequate knowledge of wound care are essential for effective treatment of paraneoplastic pemphigus, which is managed similarly to toxic epidermal necrolysis and burn patients. A wound care nurse should be involved in the care of these patients, and keep the concerned provider apprised of all progress. The patient requires education by the nurse on the different occlusive dressings and the importance of antiseptic baths. The nurse has to monitor the wounds for superinfection and report any changes to the provider. A mental health nurse should also be involved in the care of these patients as the disorder can cause severe distress, anxiety, and depression. A specialty-trained pharmacist must be involved to verify agent selection and dosing when medication is part of the therapy plan, and as always, check for drug-drug interactions. Dieticians aid in the development of dietary plans and nutrient supplementation, especially if the patient requires tube feeds secondary to oropharyngeal involvement.</p>
        <p>With comprehensive management by the interprofessional healthcare team, the quality of life of these patients with paraneoplastic pemphigus can be improved. [Level 5]</p>
      </sec>
      <sec id="article-26887.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26887&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26887">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/paraneoplastic-pemphigus/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26887">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26887/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26887">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26887.s16">
        <title>References</title>
        <ref id="article-26887.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kasperkiewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ellebrecht</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2017</year>
            <month>May</month>
            <day>11</day>
            <volume>3</volume>
            <fpage>17026</fpage>
            <pub-id pub-id-type="pmid">28492232</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vassileva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Drenovska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Manuelyan</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune blistering dermatoses as systemic diseases.</article-title>
            <source>Clin Dermatol</source>
            <year>2014</year>
            <season>May-Jun</season>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>364</fpage>
            <page-range>364-75</page-range>
            <pub-id pub-id-type="pmid">24767184</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sehgal</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome.</article-title>
            <source>Int J Dermatol</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-9</page-range>
            <pub-id pub-id-type="pmid">19200194</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kelly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schifter</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fulcher</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus: two cases of intra-abdominal malignancy presenting solely as treatment refractory oral ulceration.</article-title>
            <source>J Dermatol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>3</issue>
            <fpage>300</fpage>
            <page-range>300-4</page-range>
            <pub-id pub-id-type="pmid">25557248</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czernik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Camilleri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pittelkow</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Grando</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic autoimmune multiorgan syndrome: 20 years after.</article-title>
            <source>Int J Dermatol</source>
            <year>2011</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>8</issue>
            <fpage>905</fpage>
            <page-range>905-14</page-range>
            <pub-id pub-id-type="pmid">21781058</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Jabs</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Kory</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ratrie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mutasim</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ariss-Abdo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.</article-title>
            <source>N Engl J Med</source>
            <year>1990</year>
            <month>Dec</month>
            <day>20</day>
            <volume>323</volume>
            <issue>25</issue>
            <fpage>1729</fpage>
            <page-range>1729-35</page-range>
            <pub-id pub-id-type="pmid">2247105</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nguyen</surname>
                <given-names>VT</given-names>
              </name>
              <name>
                <surname>Ndoye</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bassler</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Shultz</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Ruben</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Webber</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Pittelkow</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Grando</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.</article-title>
            <source>Arch Dermatol</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>137</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-206</page-range>
            <pub-id pub-id-type="pmid">11176692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yong</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Tey</surname>
                <given-names>HL</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus.</article-title>
            <source>Australas J Dermatol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>241</fpage>
            <page-range>241-50</page-range>
            <pub-id pub-id-type="pmid">22759072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hodak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Calderon</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations.</article-title>
            <source>Oral Oncol</source>
            <year>2004</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>6</issue>
            <fpage>553</fpage>
            <page-range>553-62</page-range>
            <pub-id pub-id-type="pmid">15063382</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kartan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>VY</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-126</page-range>
            <pub-id pub-id-type="pmid">27878477</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pollmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-25</page-range>
            <pub-id pub-id-type="pmid">29313220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akel</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fakhri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Salem</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boulos</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Habib</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tfayli</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Pemphigus as a First Manifestation of an Intra-Abdominal Follicular Dendritic Cell Sarcoma: Rare Case and Review of the Literature.</article-title>
            <source>Case Rep Oncol</source>
            <year>2018</year>
            <season>May-Aug</season>
            <volume>11</volume>
            <issue>2</issue>
            <fpage>353</fpage>
            <page-range>353-359</page-range>
            <pub-id pub-id-type="pmid">29928216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma: report of a case and review of literature.</article-title>
            <source>Int J Clin Exp Pathol</source>
            <year>2015</year>
            <volume>8</volume>
            <issue>10</issue>
            <fpage>11983</fpage>
            <page-range>11983-94</page-range>
            <pub-id pub-id-type="pmid">26722384</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lim</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Pemphigus Associated with a Malignant Thymoma: A Case of Persistent and Refractory Oral Ulcerations Following Thymectomy.</article-title>
            <source>Ann Dermatol</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>219</fpage>
            <page-range>219-222</page-range>
            <pub-id pub-id-type="pmid">28392652</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wong</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>KK</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus with pemphigoid-like presentation, associated with squamous cell carcinoma of the tongue.</article-title>
            <source>Australas J Dermatol</source>
            <year>2000</year>
            <month>Aug</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-80</page-range>
            <pub-id pub-id-type="pmid">10954991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hayanga</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Pannucci</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Knipp</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Olsen</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Napolitano</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus in a burn intensive care unit: case report and review of the literature.</article-title>
            <source>J Burn Care Res</source>
            <year>2010</year>
            <season>Sep-Oct</season>
            <volume>31</volume>
            <issue>5</issue>
            <fpage>826</fpage>
            <page-range>826-9</page-range>
            <pub-id pub-id-type="pmid">20683196</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Lazarova</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Aho</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kazerounian</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kouba</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Mascaro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nousari</surname>
                <given-names>HC</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus in children and adolescents.</article-title>
            <source>Br J Dermatol</source>
            <year>2002</year>
            <month>Oct</month>
            <volume>147</volume>
            <issue>4</issue>
            <fpage>725</fpage>
            <page-range>725-32</page-range>
            <pub-id pub-id-type="pmid">12366419</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Loiseau</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Busson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lepage</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Mouquet</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Courville</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Flageul</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Charron</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Musette</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tron</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus is associated with the DRB1*03 allele.</article-title>
            <source>J Autoimmun</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>91</fpage>
            <page-range>91-5</page-range>
            <pub-id pub-id-type="pmid">12604316</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Bu</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>XJ</given-names>
              </name>
            </person-group>
            <article-title>Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus.</article-title>
            <source>Br J Dermatol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>158</volume>
            <issue>3</issue>
            <fpage>587</fpage>
            <page-range>587-91</page-range>
            <pub-id pub-id-type="pmid">18070207</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lane</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Woody</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Guill</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Jerath</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus) in a child: case report and review of the literature.</article-title>
            <source>Pediatrics</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>e513</fpage>
            <page-range>e513-6</page-range>
            <pub-id pub-id-type="pmid">15466078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sakuma</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morioka</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kitamura</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sasai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Imamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Inaba</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>The incidence of internal malignancies in pemphigus and bullous pemphigoid in Japan.</article-title>
            <source>J Dermatol Sci</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-41</page-range>
            <pub-id pub-id-type="pmid">7772576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paolino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Didona</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Magliulo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Iannella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Didona</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mercuri</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Moliterni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciofalo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Granata</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ranuzzi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Falasca</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Calvieri</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy.</article-title>
            <source>Int J Mol Sci</source>
            <year>2017</year>
            <month>Nov</month>
            <day>26</day>
            <volume>18</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">29186863</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsuchisaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Numata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teye</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Natsuaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takeda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Koga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sogame</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Takamori</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hoshino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Brandt</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Pas</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Epiplakin Is a Paraneoplastic Pemphigus Autoantigen and Related to Bronchiolitis Obliterans in Japanese Patients.</article-title>
            <source>J Invest Dermatol</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>136</volume>
            <issue>2</issue>
            <fpage>399</fpage>
            <page-range>399-408</page-range>
            <pub-id pub-id-type="pmid">26802236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ohzono</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sogame</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Teye</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsuchisaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Numata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kawakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tsuruta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.</article-title>
            <source>Br J Dermatol</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>173</volume>
            <issue>6</issue>
            <fpage>1447</fpage>
            <page-range>1447-52</page-range>
            <pub-id pub-id-type="pmid">26358412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Numata</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Teye</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsuruta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sogame</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Koga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Natsuaki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tsuchisaka</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamada</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Karashima</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Furumura</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ohata</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kawakami</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schepens</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Anti-&#x003b1;-2-macroglobulin-like-1 autoantibodies are detected frequently and may be pathogenic in paraneoplastic pemphigus.</article-title>
            <source>J Invest Dermatol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>133</volume>
            <issue>7</issue>
            <fpage>1785</fpage>
            <page-range>1785-93</page-range>
            <pub-id pub-id-type="pmid">23407400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schepens</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jaunin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Begre</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>L&#x000e4;derach</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Marcus</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Favre</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>The protease inhibitor alpha-2-macroglobulin-like-1 is the p170 antigen recognized by paraneoplastic pemphigus autoantibodies in human.</article-title>
            <source>PLoS One</source>
            <year>2010</year>
            <month>Aug</month>
            <day>18</day>
            <volume>5</volume>
            <issue>8</issue>
            <fpage>e12250</fpage>
            <pub-id pub-id-type="pmid">20805888</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amber</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Valdebran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Grando</surname>
                <given-names>SA</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus.</article-title>
            <source>Autoimmun Rev</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>17</volume>
            <issue>10</issue>
            <fpage>1002</fpage>
            <page-range>1002-1010</page-range>
            <pub-id pub-id-type="pmid">30103046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bu</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>XJ</given-names>
              </name>
            </person-group>
            <article-title>Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2009</year>
            <month>Mar</month>
            <day>05</day>
            <volume>122</volume>
            <issue>5</issue>
            <fpage>486</fpage>
            <page-range>486-95</page-range>
            <pub-id pub-id-type="pmid">19323896</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Horn</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Histologic features of paraneoplastic pemphigus.</article-title>
            <source>Arch Dermatol</source>
            <year>1992</year>
            <month>Aug</month>
            <volume>128</volume>
            <issue>8</issue>
            <fpage>1091</fpage>
            <page-range>1091-5</page-range>
            <pub-id pub-id-type="pmid">1497365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus.</article-title>
            <source>J Dermatol</source>
            <year>2007</year>
            <month>Aug</month>
            <volume>34</volume>
            <issue>8</issue>
            <fpage>503</fpage>
            <page-range>503-11</page-range>
            <pub-id pub-id-type="pmid">17683379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Richard</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Courville</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chosidow</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Roujeau</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Beylot-Barry</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'incan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Martel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lauret</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tron</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>619</fpage>
            <page-range>619-26</page-range>
            <pub-id pub-id-type="pmid">11004616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solimani</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Maglie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pollmann</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tackenberg</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kirschbaum</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Didona</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pickert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Thymoma-Associated Paraneoplastic Autoimmune Multiorgan Syndrome-From Pemphigus to Lichenoid Dermatitis.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1413</fpage>
            <pub-id pub-id-type="pmid">31293579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wieczorek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Czernik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus: a short review.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2016</year>
            <volume>9</volume>
            <fpage>291</fpage>
            <page-range>291-295</page-range>
            <pub-id pub-id-type="pmid">27729809</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyers</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Varley</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Meisler</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Camisa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wander</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Conjunctival involvement in paraneoplastic pemphigus.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1992</year>
            <month>Nov</month>
            <day>15</day>
            <volume>114</volume>
            <issue>5</issue>
            <fpage>621</fpage>
            <page-range>621-4</page-range>
            <pub-id pub-id-type="pmid">1443026</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1259</fpage>
            <pub-id pub-id-type="pmid">31214197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Broussard</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Leung</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Moradi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Thorne</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Fine</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplastica.</article-title>
            <source>Clin Dermatol</source>
            <year>2016</year>
            <season>Mar-Apr</season>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-13</page-range>
            <pub-id pub-id-type="pmid">26903186</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wade</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus: a brief update.</article-title>
            <source>Australas J Dermatol</source>
            <year>2005</year>
            <month>Feb</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-8; quiz 9-10</page-range>
            <pub-id pub-id-type="pmid">15670168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ouedraogo</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Masson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lepelletier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jachiet</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Salle de Chou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Galicier</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bagot</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chevret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bouaziz</surname>
                <given-names>JD</given-names>
              </name>
            </person-group>
            <article-title>Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>80</volume>
            <issue>6</issue>
            <fpage>1544</fpage>
            <page-range>1544-1549</page-range>
            <pub-id pub-id-type="pmid">30981429</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mao</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus and myasthenia gravis, associated with inflammatory pseudotumor-like follicular dendritic cell sarcoma: response to rituximab.</article-title>
            <source>Clin Case Rep</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>4</volume>
            <issue>8</issue>
            <fpage>797</fpage>
            <page-range>797-9</page-range>
            <pub-id pub-id-type="pmid">27525088</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kershenovich</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hodak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and classification of pemphigus and bullous pemphigoid.</article-title>
            <source>Autoimmun Rev</source>
            <year>2014</year>
            <season>Apr-May</season>
            <volume>13</volume>
            <issue>4-5</issue>
            <fpage>477</fpage>
            <page-range>477-81</page-range>
            <pub-id pub-id-type="pmid">24424192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Poot</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Diercks</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Kramer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schepens</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Klunder</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Pas</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Laboratory diagnosis of paraneoplastic pemphigus.</article-title>
            <source>Br J Dermatol</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>169</volume>
            <issue>5</issue>
            <fpage>1016</fpage>
            <page-range>1016-24</page-range>
            <pub-id pub-id-type="pmid">23796242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camisa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Helm</surname>
                <given-names>TN</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease.</article-title>
            <source>Arch Dermatol</source>
            <year>1993</year>
            <month>Jul</month>
            <volume>129</volume>
            <issue>7</issue>
            <fpage>883</fpage>
            <page-range>883-6</page-range>
            <pub-id pub-id-type="pmid">8323311</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rado&#x00161;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune blistering diseases: histologic meaning.</article-title>
            <source>Clin Dermatol</source>
            <year>2011</year>
            <season>Jul-Aug</season>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>377</fpage>
            <page-range>377-88</page-range>
            <pub-id pub-id-type="pmid">21679865</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zimmermann</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bahmer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Clinical and immunopathological spectrum of paraneoplastic pemphigus.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>598</fpage>
            <page-range>598-606</page-range>
            <pub-id pub-id-type="pmid">20180886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powell</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Plunkett</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Seiffert-Sinha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of a Newly Available ELISA for Envoplakin Autoantibodies for the Diagnosis of Paraneoplastic Pemphigus.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>10</issue>
            <fpage>1103</fpage>
            <page-range>1103-6</page-range>
            <pub-id pub-id-type="pmid">26461820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Probst</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schlumberger</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>St&#x000f6;cker</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Recke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>XJ</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Komorowski</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Development of ELISA for the specific determination of autoantibodies against envoplakin and periplakin in paraneoplastic pemphigus.</article-title>
            <source>Clin Chim Acta</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>410</volume>
            <issue>1-2</issue>
            <fpage>13</fpage>
            <page-range>13-8</page-range>
            <pub-id pub-id-type="pmid">19737550</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Picard</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ingen-Housz-Oro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arnault</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Aubin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carsuzaa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Chaumentin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Chevrant-Breton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Chosidow</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Crickx</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>D'incan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dandurand</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Debarbieux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Delaporte</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dereure</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Doutre</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Guillet</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Jullien</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kupfer</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lacour</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Leonard</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lok</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Machet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pignon</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Robert</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Weiller</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Ferranti</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Courville</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Houivet</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Benichou</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Prognostic factors of paraneoplastic pemphigus.</article-title>
            <source>Arch Dermatol</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>148</volume>
            <issue>10</issue>
            <fpage>1165</fpage>
            <page-range>1165-72</page-range>
            <pub-id pub-id-type="pmid">22801794</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kikuchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mori</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Koda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Abe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kurihara</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Funakoshi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tsunoda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Okamoto</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Successful treatment with bendamustine and rituximab for paraneoplastic pemphigus.</article-title>
            <source>Ann Hematol</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>1221</fpage>
            <page-range>1221-1222</page-range>
            <pub-id pub-id-type="pmid">28447163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bech</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Baumgartner-Nielsen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peterslund</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Steiniche</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Deleuran</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>d'Amore</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.</article-title>
            <source>Br J Dermatol</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>169</volume>
            <issue>2</issue>
            <fpage>469</fpage>
            <page-range>469-72</page-range>
            <pub-id pub-id-type="pmid">23517368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hohwy</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Steiniche</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Peterslund</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>d'Amore</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia.</article-title>
            <source>Eur J Haematol</source>
            <year>2004</year>
            <month>Sep</month>
            <volume>73</volume>
            <issue>3</issue>
            <fpage>206</fpage>
            <page-range>206-9</page-range>
            <pub-id pub-id-type="pmid">15287918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCuin</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Hanlon</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mutasim</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune bullous diseases: diagnosis and management.</article-title>
            <source>Dermatol Nurs</source>
            <year>2006</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-5</page-range>
            <pub-id pub-id-type="pmid">16550892</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powers</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Higham</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Broussard</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>TJ</given-names>
              </name>
            </person-group>
            <article-title>Wound healing and treating wounds: Chronic wound care and management.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>607</fpage>
            <page-range>607-25; quiz 625-6</page-range>
            <pub-id pub-id-type="pmid">26979353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;a</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marinovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Daneshpazhooh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Culton</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Czernik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zone</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Fivenson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ujiie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wozniak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Akman-Karaka&#x0015f;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Caux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Drenovska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Prost-Squarcioni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vassileva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cardones</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ioannides</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jedlickova</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Palisson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Patsatsi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uzun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yayli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Grando</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cianchini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Feliciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iranzo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mascar&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kowalewski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Groves</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harman</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Maverakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Werth</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of pemphigus: Recommendations of an international panel of experts.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>82</volume>
            <issue>3</issue>
            <fpage>575</fpage>
            <page-range>575-585.e1</page-range>
            <pub-id pub-id-type="pmid">29438767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nousari</surname>
                <given-names>HC</given-names>
              </name>
              <name>
                <surname>Deterding</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wojtczack</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Aho</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>The mechanism of respiratory failure in paraneoplastic pemphigus.</article-title>
            <source>N Engl J Med</source>
            <year>1999</year>
            <month>May</month>
            <day>06</day>
            <volume>340</volume>
            <issue>18</issue>
            <fpage>1406</fpage>
            <page-range>1406-10</page-range>
            <pub-id pub-id-type="pmid">10228191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>QL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>XX</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Qiu</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>JX</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>YC</given-names>
              </name>
              <name>
                <surname>Wan</surname>
                <given-names>YL</given-names>
              </name>
            </person-group>
            <article-title>Improved outcomes after complete resection of underlying tumors for patients with paraneoplastic pemphigus: a single-center experience of 22 cases.</article-title>
            <source>J Cancer Res Clin Oncol</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>137</volume>
            <issue>2</issue>
            <fpage>229</fpage>
            <page-range>229-34</page-range>
            <pub-id pub-id-type="pmid">20390428</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nikolskaia</surname>
                <given-names>OV</given-names>
              </name>
              <name>
                <surname>Nousari</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Anhalt</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Paraneoplastic pemphigus in association with Castleman's disease.</article-title>
            <source>Br J Dermatol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>149</volume>
            <issue>6</issue>
            <fpage>1143</fpage>
            <page-range>1143-51</page-range>
            <pub-id pub-id-type="pmid">14674890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26887.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frew</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome).</article-title>
            <source>Dermatol Clin</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>607</fpage>
            <page-range>607-12</page-range>
            <pub-id pub-id-type="pmid">21925005</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
